{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:37:07Z","timestamp":1777916227091,"version":"3.51.4"},"reference-count":32,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Women's Health"],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Bone mineral density (BMD) loss among depot medroxyprogesterone acetate (DMPA) users is a controversial issue. Aspects under debate include whether the number of years of use has any effect on continuous BMD loss, whether this loss will stabilise over the years of use or if it will progress to low bone mass, osteoporosis and an increased fracture risk. The aim of this study was to compare the difference in osteoporosis and low bone mass between DMPA and copper intrauterine device (Cu-IUD) users.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional study that evaluated BMD at the lumbar spine and femoral neck in 47 long-term DMPA users and 41 Cu-IUD users as control group. BMD was measured by dual-energy X-ray absorptiometry. The participants were 27 to 57 years of age, had used either DMPA or a Cu-IUD uninterruptedly for at least ten years, had initiated use of the method prior to 40 years of age and had follicle stimulating hormone values &lt;40\u2009mIU\/mL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Findings showed that 68.1% and 36.6% of the DMPA and Cu-IUD users, respectively, had low bone mass and 29.8% and 2.4% of DMPA and Cu-IUD users, respectively, had osteoporosis. BMD decreased as the number of years of DMPA use increased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Long-term DMPA use was associated with low bone mass and osteoporosis in women who had used the method for 10 years or more. DMPA users with longer time of use showed a greater bone mass loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jwh.2014.5077","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T12:15:27Z","timestamp":1434975327000},"page":"636-640","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":28,"title":["Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate"],"prefix":"10.1177","volume":"24","author":[{"given":"Waleska","family":"Modesto","sequence":"first","affiliation":[{"name":"University of Campinas","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Valeria","family":"Bahamondes","sequence":"additional","affiliation":[{"name":"University of Campinas","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Bahamondes","sequence":"additional","affiliation":[{"name":"University of Campinas","place":["Brazil"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,8]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318188d1ec"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110855"},{"issue":"7","key":"e_1_3_3_4_2","first-page":"CD006033","article-title":"Steroidal contraceptives: Effect on bone fractures in women","author":"Lopez LM","year":"2011","unstructured":"Lopez LM, , Grimes DA, , Schulz KF, et al. Steroidal contraceptives: Effect on bone fractures in women. Cochrane Database Syst Rev, 2011;(7):CD006033.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_5_2","first-page":"569","article-title":"Spinal bone density in women using depot medroxyprogesterone contraception","volume":"92","author":"Cundy T","year":"1998","unstructured":"Cundy T, , Cornish J, , Roberts H, et al. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol, 1998; 92:569\u2013573.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2003.10.005"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1465-5"},{"issue":"80","key":"e_1_3_3_8_2","first-page":"302","article-title":"Statement on hormonal contraception and bone health","volume":"2","author":"World Health Organization (WHO)","year":"2005","unstructured":"World Health Organization (WHO). Statement on hormonal contraception and bone health. Wkly Epidemiol Rec, 2005; 2; 80:302\u2013304.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10211.x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.2217\/WHE.10.17"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(98)00144-9"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200209000-00015"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.04.064"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6923.247"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.10.070"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318283d1a1"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170155"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.07.014"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2006.09.003"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000117082.49490.d5"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.06.012"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.01.009"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(00)00168-2"},{"key":"e_1_3_3_24_2","first-page":"116","article-title":"Status of bone mineral density after the long-standing application of contraception Depo-Provera","volume":"78","author":"Zeman S","year":"2013","unstructured":"Zeman S, , Havl\u00edk P, , Zemanov\u00e1 J, et al. Status of bone mineral density after the long-standing application of contraception Depo-Provera. Ceska Gynekol, 2013; 78:116\u2013124.","journal-title":"Ceska Gynekol"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181875b78"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2004.09.003"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.122420"},{"key":"e_1_3_3_28_2","unstructured":"Food and Drugs Administration (FDA) (2004) Pfizer update information for Depo-provera. Available online at www.fda.gov\/downloads\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/UCM166395.pdf Accessed April2 2014."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050158"},{"key":"e_1_3_3_30_2","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA). Updated Guidance on the Use of Depo-Provera Contraception. 2004. Available online at www.mhra.gov.uk\/Safetyinformation\/Safetywarningsalertsandrecalls\/Safetywarningsandmessagesformedicines\/CON1004262 Accessed January18 2014."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.01.002"},{"key":"e_1_3_3_32_2","unstructured":"The UK National Institute for Health and Care Excellence (NICE). Research recommendation 2005. Available online at www.nice.org.uk\/research Accessed January26 2014."},{"key":"e_1_3_3_33_2","unstructured":"World Health Organization. Who Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. Summary meeting report Brussels Belgium May 5\u20137 2004. Available online at www.who.int\/chp\/topics\/Osteoporosis.pdf Accessed November24 2014."}],"container-title":["Journal of Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jwh.2014.5077","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2014.5077","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jwh.2014.5077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:42:15Z","timestamp":1777657335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/jwh.2014.5077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.1089\/jwh.2014.5077"],"URL":"https:\/\/doi.org\/10.1089\/jwh.2014.5077","relation":{},"ISSN":["1540-9996","1931-843X"],"issn-type":[{"value":"1540-9996","type":"print"},{"value":"1931-843X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}